[Clinical Application of Two Bleeding Scoring Scales in Children with Primary Immune Thrombocytopenia]

Fu Liu1,2, Chun-Yan DU2, Tao Hu2

  • 1Department of Pediatrics, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou 646000, Sichuan Province, China.

PubMed

Insights

The 2019 Pediatric ITP Scale effectively assesses bleeding in children with immune thrombocytopenia (ITP). This scale shows good consistency and sensitivity, making it a valuable tool for disease management.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Clinical Diagnostics

Context:

  • Primary immune thrombocytopenia (ITP) is a bleeding disorder affecting children.
  • Accurate assessment of bleeding severity is crucial for effective ITP management.
  • Existing bleeding scoring scales require validation for pediatric populations.

Purpose:

  • To evaluate the clinical utility of the 2019 Pediatric ITP Scale in diagnosing and managing pediatric primary ITP.
  • To compare the 2019 Pediatric ITP Scale with the 2013 ITP-BAT in terms of consistency, time efficiency, and responsiveness to treatment.

Summary:

  • The 2019 Pediatric ITP Scale demonstrated good consistency (rs=0.7638) and sensitivity in assessing bleeding in 422 children with ITP.
  • The scale showed a significant negative correlation with platelet counts and was quicker to administer (88.64s vs 104.12s) than the 2013 ITP-BAT.
  • The 2019 Pediatric ITP Scale effectively reflected treatment response, showing significant changes in scores post-treatment across different therapeutic groups.

Impact:

  • The 2019 Pediatric ITP Scale is a reliable and efficient tool for disease assessment and efficacy determination in pediatric primary ITP.
  • Its ease of use and validated accuracy can improve clinical decision-making and patient outcomes in pediatric hematology.
  • This scale facilitates standardized bleeding assessment, aiding in comparative studies and treatment guideline development.
Abstract